Preliminary findings for the validity of the Morningness-Eveningness-Stability Scale improved (MESSi): Correlations with activity levels and personality.

Aim of the present study is an additional validation of the Morningness-Eveningness-Stability Scale improved (MESSi). We screened a total of 97 German students using the reduced Morningness-Eveningness Questionnaire (rMEQ) to identify a subsample (N = 42) of definite morning and evening types (31% males, mean age: 24.8 ± 5.

From Lark to Owl: developmental changes in morningness-eveningness from new-borns to early adulthood.

Morningness-eveningness or chronotype changes significantly throughout the life span. This has been reported for the transition during adolescence in some studies, and to a lesser extent in early adulthood. Primary and pre-school children have been under investigation in fewer studies.

The polymyalgia rheumatica activity score in daily use: proposal for a definition of remission.

Objective: To confirm the reliability and applicability of the Polymyalgia Rheumatica Disease Activity Score (PMR-AS), and to establish a threshold for remission.

Methods: First, 78 patients with PMR (50 women/28 men, mean age 65.97 years) were enrolled in a cross-sectional evaluation.

Lack of agreement between patients' and physicians' perspectives of rheumatoid arthritis disease activity changes.

Objective: To obtain information on changes in patients' satisfaction (PATSAT) and physicians' global assessment (PhGASS) with regard to rheumatoid arthritis (RA) activity fluctuations.

Methods: Eighty-eight RA outpatients out of 207 investigated were assessed for 3 months on average after the initial evaluation. PATSAT (1 = excellent to 5 = unsatisfactory), PhGASS (visual analogue scale 1-100), and the 28-joint Disease Activity Score (DAS28) were assessed as at the first evaluation.

The Disease Activity Score in 28 joints in rheumatoid arthritis and psoriatic arthritis patients.

Objective: To assess the factorial structure of the Disease Activity Score including a 28-joint count (DAS28) if applied in patients with rheumatoid arthritis (RA) and psoriatic arthritis (PsA).

Methods: DAS28 values from 85 consecutive PsA outpatients and 2 RA patient cohorts comprising 85 patients each were compared. The first RA cohort (RA1) consisted of age- and sex-matched patients seen during the same period as the patients with PsA.